BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2026 9:50:50 AM | Browse: 53 | Download: 121
 |
Received |
|
2025-10-10 01:02 |
|
Peer-Review Started |
|
2025-10-10 01:02 |
|
First Decision by Editorial Office Director |
|
2025-11-05 09:10 |
|
Return for Revision |
|
2025-11-05 09:10 |
|
Revised |
|
2025-11-16 16:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-23 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-23 07:33 |
|
Articles in Press |
|
2025-12-23 07:33 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-04 03:46 |
|
Publish the Manuscript Online |
|
2026-01-12 09:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
The triglyceride-glucose index shows promise as a novel prognostic marker for advanced hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tao Xu, Xu Qi, Fei-Yu Zhao and Nian-Song Qian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fei-Yu Zhao, PhD, Department of Radiation Oncology, The Fifth Medical Center of Chinese People’s Liberation Army General Hospital, No. 8 East Main Street, Fengtai District, Beijing 100071, China. 1029279130@qq.com |
| Key Words |
Triglyceride-glucose index; Prognostic marker; Advanced hepatocellular carcinoma; Camrelizumab; Lenvatinib |
| Core Tip |
This commentary highlights triglyceride-glucose (TyG) index as a prognostic marker for hepatitis B virus-related advanced hepatocellular carcinoma on camrelizumab-lenvatinib. Low TyG (< 1.58) boosts survival, it’s an independent predictor, with limitations needing multicenter studies. |
| Publish Date |
2026-01-12 09:50 |
| Citation |
Xu T, Qi X, Zhao FY, Qian NS. The triglyceride-glucose index shows promise as a novel prognostic marker for advanced hepatocellular carcinoma. World J Gastroenterol 2026; 32(2): 115178 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i2/115178.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i2.115178 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
